Article Text
Abstract
Introduction Increased physical activity and reduced sedentary behaviour can encourage favourable outcomes after bariatric surgery. However, there is a lack of evidence as to how to support patients with behaviour change. The aim of this study is to assess the feasibility of a physiotherapist led, online group-based behaviour change intervention to increase physical activity and reduce sedentary behaviour following bariatric surgery.
Methods and analysis Single arm feasibility study of a theory and evidence-based group behaviour change intervention based on the Behaviour Change Wheel and Theoretical Domains Framework using behaviour change techniques from the Behaviour Change Technique Taxonomy v1. The intervention has eight objectives and specifies behaviour change techniques that will be used to address each of these. Groups of up to eight participants who have had surgery within the previous 5 years will meet weekly over 6 weeks for up to 1½ hours. Groups will be held online led by a physiotherapist and supported by an intervention handbook. Feasibility study outcomes include: rate of recruitment, retention, intervention fidelity, participant engagement and acceptability. Secondary outcomes include: physical activity, sedentary behaviour, body composition, self-reported health status and will be analysed descriptively. Change in these outcomes will be used to calculate the sample size for a future evaluation study. Qualitative interviews will explore participants’ views of the intervention including its acceptability. Data will be analysed according to the constant comparative approach of grounded theory.
Ethics and dissemination This study has National Health Service Research Ethics Committee approval; Haydock 20/NW/0472. All participants will provide informed consent and can withdraw at any point. Findings will be disseminated through peer-reviewed journals, conference and clinical service presentations.
Trial registration number ISRCTN31524689.
- rehabilitation medicine
- diabetes & endocrinology
- public health
This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
Statistics from Altmetric.com
Strengths and limitations of this study
This is a pragmatic single arm study evaluating a theory and evidence-based group intervention, which was developed through evidence synthesis, review of relevant theory and qualitative research with the patient population, clinicians and commissioners.
We have identified that it would be inappropriate to immediately progress to a full trial, and thus designed a single site feasibility study with our patient and public involvement group, that can answer study and intervention uncertainties.
We have outlined our protocol for a group behaviour change intervention, delivered online to a clinically vulnerable patient group during a worldwide pandemic.
Introduction
Background and rationale
Obesity is defined as an excessive accumulation of adiposity that presents a risk to health, this is often indicated by a body mass index (BMI) greater than 30 kg/m².1 It is a non-communicable disease, and is associated with serious conditions including type 2 diabetes, cardiovascular disease, obstructive sleep apnoea and some cancers.2 Most recently the seriousness of obesity has been highlighted with data showing that people with obesity have an increased susceptibility to serious disease and mortality from COVID-19 when compared with the general population.3 4
The most effective treatment for severe obesity (BMI ≥35 with obesity-related complications or ≥40 without) is bariatric surgery. It rapidly induces significant weight loss and can improve complications of obesity such as type 2 diabetes.5 Surgery however is not a cure; weight can be regained so associated conditions can return,6–8 as a result there is increasing attention to long-term outcomes and how patients might be supported to optimise weight maintenance, physical function and to reduce complications of obesity in the longer term.9
Evidence from systematic reviews and meta-analyses shows that patients who are more physically active after bariatric surgery optimise their weight and fat mass loss and improved their fitness compared with those who do not.10 11 Evidence from a randomised control trial of 60 patients with a BMI ≥35 kg/m² randomised to either aerobic exercise, aerobic-strength exercises or control conditions found a greater reduction in weight, per cent body fat and fat mass in the intervention groups when compared with the control, which was statistically significant. Reduction in fat free mass was significantly lower in the aerobic-strength group when compared with the others.12 However, not everyone who undergoes bariatric surgery becomes more physically active. Evidence from a systematic review and meta-analysis identified that although self-report and objective physical activity (PA) increased at 12 months post surgery, this manifested as an increase in lower intensity PA and a reduction in moderate-to-vigorous intensity PA (MVPA).13 A longitudinal study compared levels of PA before surgery and 6 months thereafter using self-report and objective measures (accelerometery). Prior to surgery 10% of participants met the PA guidelines for health of 150 min/week MVPA according to both outcome tools. Post surgery this increased to 55% according to self-report but was not supported by accelerometer data which showed that only 5% of participants achieved this.14 Thus, it is likely that in post-surgical care, patients will report higher than actual levels of PA. Another behaviour of interest in this study is sedentary behaviour (SB). A transient increase in SB is associated with significant reductions in insulin sensitivity, decreased lower limb lean muscle mass and increased body fat,15 which is particularly relevant to this patient group who are already at risk of metabolic disease.
We have conducted a systematic review that has identified that to our knowledge, there have not been any studies that have been appropriately powered to detect a change in PA or SB in people who have undergone bariatric surgery. Our review included studies where an intervention was delivered either pre-bariatric or post-bariatric surgery as long as there were post-surgical measures of PA, SB or both.16 Much of the focus in the literature, is on the physiological effects of changing these target behaviours as opposed to how to facilitate changes. Where the effect of an intervention on these behaviours is considered it tends to be because they are part of a battery of outcome measures rather than being the primary outcome or behaviour of interest. Many interventions are poorly described in terms of the theory-base; behaviour change techniques are not always described according to the taxonomy and the rationale for their use is not clearly explained.16 This lack of detail makes replication of intervention conditions challenging. Furthermore, assessment of fidelity and review of engagement beyond recording the number of sessions attended makes it difficult to ascertain if the interventions have been delivered and received as intended.17–19 Thus, there is an evidence gap for interventions that aim to increase PA and reduce SB in patients who have undergone bariatric surgery that this study seeks to address.
To summarise, there is a need for high quality studies, based on theory and evidence that target PA and SB, must be accurately described, clearly communicated and transparently evaluated.
The proposed study is a feasibility study of a group, theory-based intervention delivered online using a widely available platform (Zoom) which will be supported by an intervention handbook.
The intervention development is robust; it is the result of evidence synthesis, review of relevant theory and qualitative research with the patient population, clinicians and commissioners. Evidence has been mapped against the Behaviour Change Wheel, which includes the COM-B model and the Theoretical Domains Framework.20 21 The intervention has eight objectives which will be met over the course of six intervention session, each of which will be 1–1½ hours in duration.
Aim and objectives
The lack of evidence for interventions to increase PA and reduce SB means that it would be inappropriate to progress to a full-scale evaluation trial, and thus a feasibility study is warranted.
The aim of this study is to assess the feasibility of single arm, physiotherapist led, online group-based behaviour change intervention to increase PA and reduce SB following bariatric surgery. Once we have conducted this study we will be able to determine if the intervention could be evaluated in a future definitive study.
The objectives relate to uncertainties and are as follows:
To ascertain recruitment and retention to the intervention and study.
To investigate fidelity of the intervention, participant engagement with and acceptability of the intervention.
To test the feasibility of study outcome measures: questionnaires, accelerometery and dual energy X-ray absorptiometry (DEXA) scan.
To estimate the necessary sample size for a future evaluation study based on the chosen outcome measures.
Design
This is a pragmatic feasibility study evaluating a group-based behaviour change intervention that seeks to support people who have had bariatric surgery to increase their levels of PA and reduce SB. Groups will comprise up to six participants, who will satisfy the inclusion and exclusion criteria below.
Methods: participants, interventions and outcomes
Patient and public involvement
A patient and public involvement (PPI) group, comprising three members who have previously undergone bariatric surgery, was recruited via Obesity UK at the start of development work and they have inputted into both the intervention and study design of this and previous studies, over approximately a 3-year period. They have helped to develop the research question, inputted into development work, helped to refine intervention objectives and have influenced study design. An example of this is their absolute rejection of the initial proposal to include randomisation to either the intervention or standard care group as they felt support to increase PA and reduce SB would be beneficial for anyone who had undergone bariatric surgery, thus randomisation was unacceptable.
In view of the strength of feeling from the PPI group, the current COVID-19 pandemic and the aims of this feasibility study, the team agreed with the PPI group not use a randomised design in this instance and to proceed with a single arm feasibility study. However, once we have the results of this study we will meet with the PPI group, explain the principle of equipoise and work with them on study design which will include determining an appropriate control condition. The contribution of the PPI group to this study has been invaluable, and they will continue to contribute through the trial management group (TMG) and in dissemination once the study is complete.
Study setting
The study will be conducted at Liverpool University Hospitals NHS Foundation Trust (LUH), which is a large teaching hospital located in the City of Liverpool. It is a regional centre that provides specialist multidisciplinary medical and presurgical weight management services to patients in the North West of England, who have a BMI of 35 kg/m² with comorbid conditions or a BMI of 40 kg/m² without comorbid conditions, in accordance with previous specialist commissioning guidance.22 Patients must access a specialist weight management service as a prerequisite for referral for bariatric surgery funded by the National Health Service (NHS) in England, which is what this service provides.
Sample size
This is a feasibility study and thus there is no formal sample size which has been calculated against a primary outcome measure. In future studies this is likely to be objectively measured PA or SB. A pragmatic sample size range has been set for 12–24 participants. Twelve is the minimum recommended sample size for a feasibility study23; successfully recruiting up to 24 participants would allow a more precise sample size calculation for a future trial.
Eligibility criteria
Participants eligible for inclusion in this study must meet the following criteria at screening:
Bariatric surgery within the previous 5 years (eg, single anastomosis gastric bypass, gastric bypass, duodenal switch, sleeve gastrectomy).
Age 18+.
Able to provide written and informed consent.
Potential participants are ineligible if they have:
Gastric band or gastric balloon.
The presence of a medical condition that could compromise the participants safety if they inappropriately increased their PA, (eg, undertaking high intensity PA in the presence of poorly controlled diabetes, and acute or severe cardiac history requiring medical review). The nature of this intervention is such that closer supervision of these patients is not possible.
Bariatric surgery within the previous 8 weeks.
Any congenital cardiac condition.
Unable to converse in English.
Weight in excess of 204 kg (maximum safe working load of DEXA scanner).
Recruitment procedures
A broad and pragmatic recruitment strategy has been proposed for this study.
Posters advising of the study will be displayed in patient areas of LUH.
Obesity UK, a UK charity that supports people living with obesity who may have had or be considering bariatric surgery, will advertise the study to their members online using the same posters.
A team member will review the database of patients referred for bariatric surgery by LUH within the previous 5 years. Patients will receive an information letter with a participant information sheet enclosed advising them to contact the principal investigator (PI) if they would like to know more information or to discuss taking part.
Patients who have previously contacted the PI to express their interest in PA research will be advised of the study via email with the participant information sheet attached.
The PI (first author) will attend online support groups attended by people who have undergone bariatric surgery.
All potential participants who contact the PI regarding this study will be provided with a participant information sheet and be given the time to consider this information and ask questions prior to providing informed consent, taken by the PI. At each visit participants will be asked to reconfirm their consent. If participants are unwilling or unable to provide their consent they will be withdrawn from the study.
Intervention
The PARIS (Physical Activity and sedentary behaviouR after barIatric Surgery) intervention, is theory and evidence-based; informed by a systematic review16 to identify promising intervention components including behaviour change techniques, that are associated with interventions that were able to increase PA in this patient group. We also conducted a qualitative study with patients, clinicians and commissioners, which identified the meaning of PA for the three different stakeholder groups, influences on this and considerations for a future clinical intervention. The findings of these two pieces of research were synthesised resulting in eight intervention objectives. These objectives were then mapped against the Behaviour Change Wheel which includes the COM-B model, and against the Theoretical Domains Framework.20 21 The Theory and Techniques Tool24 informed the choice of behaviour change techniques (BCTs) from the Behaviour Change Technique Taxonomy (v1).25 BCTs could either be practically applied to the target behaviour, for example, BCT 1.1 goal setting (behaviour) where a goal is agreed and defined in terms of the behaviours (PA and SB) to be achieved,25 for example, a daily step goal or because they addressed an influence on the behaviour identified from the qualitative research, for example, BCT 5.3 information about health consequences (of being more physically active and less sedentary),25 for example, improved cardiovascular fitness.
Integral to this intervention are the handbooks; one for participants and one for facilitators, which will be available as a hard copy, electronically or both according to preference. The facilitator’s handbook mirrors that of participants’ but also includes additional information which would be superfluous for participants, such as the definitions of the BCTs used during intervention delivery.
The intervention will be delivered online using widely available software (Zoom), by an experienced Chartered Physiotherapist who is the PI on this study. The format of the sessions will be as follows: the handbooks will be used to guide the sessions and topics that are discussed. The PI will facilitate discussions between participants, providing answers only when necessary, for example, when discussing the consequences of PA, the PI will interject if participant discussions are not consistent with the evidence base. It is important to note that these are not education sessions per se, but rather sessions to support participants in making changes to their levels of PA and SB based on the evidence from our development work. Six sessions will be held over the course of 6–8 weeks, comprising up to eight people who have previously undergone bariatric surgery. Each session is expected to last between 1 and 1½ hours; it is anticipated that they will be held at the same time on the same day each week. All participants will receive the handbook, and will be encouraged to set their own goals to increase their PA and reduce their SB.
Intervention objectives are:
To explain the rationale for the intervention in the context of the observed levels of PA and SB in people who have undergone bariatric surgery.
To provide information about PA and SB; what it is, the consequences of it and how to appropriately pace and progress PA to avoid injury and delayed onset muscle soreness.
To discuss and provide information about the known consequences of increased PA and reduced SB and how this relates to the known consequences of bariatric surgery.
Provide information about the guidelines for PA and SB for different populations.
Provide information about behaviour change, using the Behaviour Change Wheel to explain the required conditions for this to take place.
Provide information about goal setting, developing implementation plans and how to appropriately evaluate behaviour change.
Provide information about the different types of motivation and how this can affect success.
To encourage participants to reflect and assess their perceived versus objectively measured levels of PA and SB.
BCTs used to meet these objectives are shown in table 1, with examples of how we think they might be used by participants.
Full details of the intervention development work and resulting intervention will be reported in a separate manuscript currently in preparation.
Outcomes
Feasibility outcomes
Uptake and retention to the study and intervention will be assessed through recruitment and screening logs which will capture the number of patients invited to participate, the number of support groups attended by the PI and those who contact the research team as a result of other recruitment strategies. An anonymised group register will be kept to record attendance at each of the sessions; and an end of study case report form will summarise study and intervention session attendance for each participant.
Intervention fidelity will be self-assessed by the PI, using audio recordings and a fidelity checklist that details the objectives of the session and BCTs to be used. All sessions of one participant group will be audio recorded for fidelity assessment. This will provide the opportunity for self-assessment and feedback in a timely manner, but might be considered a limitation as this introduces possible bias. We have already considered how we might mitigate against this in a future study, for example, by incorporating independent, timely peer-review feedback and recording every participant group so that conclusions regarding effectiveness reflect the intervention rather than suboptimal delivery of the intervention.
Engagement and acceptability of the intervention will be assessed through semi-structured interviews. Interviews will be conducted online via Zoom, or telephone and are expected to last up to 40 min. As recruitment rate and retention is unknown, the provisional target is for two participants from each group to be purposively sampled. We will aim to interview study ‘completers’, ‘non-completers’, those who have most recently had surgery, and those who are furthest out of surgery. We will also aim to interview those with the highest and lowest levels of PA and/or SB. All interviews will take place after final data collection period to avoid the interviews influencing participants’ levels of PA. An interview guide has been developed and focuses on participants’ experiences of the study and the intervention. The schedule has been reviewed and refined with the PPI group. It is expected that this will be further refined as the interviews progress, in line with the methodological approach of grounded theory according to Charmaz.26 Grounded theory has been chosen as the methodological approach as there are a number of uncertainties that we are keen to explore; such as acceptability of the study and intervention. This approach will allows us the flexibility to pursue topics as they arise, and thus our findings should be grounded in this primary qualitative research.
Study source data and case report forms will be used to assess concordance with the chosen outcome tools, for example, if accelerometers were worn and questionnaires completed as directed. Participants experience of these tools will also be explored in the semi-structured interview.
To avoid potentially confounding issues, ideally participants should not be recruited into other trials during their participation in PARIS. Where recruitment into another trial is considered to be appropriate and without having any detrimental effect to this study, this must first be discussed with the chief investigator (CI) JW.
Participant timeline
There will be four study visits in total (see figure 1 schedule of events).
Visit one will be used to check eligibility, and to obtain informed consent, which will be taken by the PI. Participant demographics and some baseline measure will also be collected. Participants will be asked to self-report their health status using the SF-36 (RAND 36-Item Health Survey V.1.0)27 28 and to wear a wrist worn accelerometer (ActiGraph GT9X Link) for the next consecutive 7 days. Visit two will be within 2 weeks of the first; the accelerometer will be returned and participants will be asked to complete the International Physical Activity Questionnaire (IPAQ) (long form) and undergo a DEXA scan, thereby completing baseline data collection. The intervention will commence within 4 weeks of visit two.
Outcomes will be assessed again at visit three (post intervention) and for a final time at visit four (follow-up) approximately 6 weeks thereafter following a period of no intervention. Thus, all outcomes are assessed at three time points; preintervention (visits 1 and 2), post intervention (visit 3) and follow-up (visit 4).
PA and SB will be measured in two ways. Self-reported data will be collected using the validated IPAQ (long form)29 and objective PA and SB will be measured using ActiGraph GT9X Link, a water resistant, wrist worn accelerometer. Participants will be instructed to wear the accelerometer for seven full days (10 080 min), removing it as little as possible. In line with evidence from a systematic review that considered the cut points for PA classification in different age groups,30 we have chosen to use the Freedson et al 31 cut points as our population concerns adults. Self-reported health status will be measured using the SF-36 (RAND 36-Item Health Survey V.1.0)27 28 and DEXA will be used to measure body composition. DEXA is an accurate low risk procedure which will be carried out by a fully qualified healthcare professional in line with established departmental safety protocols.32 33
Data management
All participants will be assigned a study identification number, which will be used on all paperwork and electronic databases. Consent forms will be stored separately from the research data; paperwork will be stored in locked cabinets and electronic databases will be password protected. All data will be accessible to the PI and CI during and after the study has completed, and will be available to sponsor and monitors as required.
Statistical methods
Quantitative data will be analysed descriptively and this will be used to calculate the sample size that would be required for a fully powered trial. Analysis will occur after the study is complete, thus there will be no interim analysis of data. As this is a feasibility study, the rate of missing data itself will be an outcome. Due to the size of the study, there is limited capacity to assess patterns of missingness across treatment groups or known prognostic factors.
Qualitative data will be collected and analysed concurrently. Descriptive analysis will be used to identify codes and overarching categories that they construct. Interpretive analysis will then be used to identify subthemes and themes to which they belong allowing a greater understanding of the participants’ experience of the intervention and the acceptability of this. This process will be iterative informed by the constant comparative approach of grounded theory,26 with the aim of generating greater understanding of participants’ experiences of the intervention.
Methods: monitoring
Data monitoring
A TMG will be formed comprising the CI, PI, coauthors, PPI group, an external postdoctoral researcher and representative from the Liverpool Clinical Trials Unit. The TMG are responsible for monitoring the progress of the study, and will meet once ethics has been approved, once during the study and once more at the end. There will be additional meetings as and when required, and all meetings will be held online. The study will be open to audit from sponsor or their appointees as required.
Harms
Adverse and serious adverse events are not expected as this study is of low risk. However, participants will be prompted to advise the research team if these occur and they will be recorded on the relevant documentation and databases, and will be followed-up as appropriate. Sponsor and LUH have the necessary insurance policies to cover any harm incurred by participants in this study.
Withdrawal from the study
Participants may discontinue their involvement in the study for a number of reasons including, but not limited to:
Request by the participant.
Intercurrent illness.
Pregnancy if the participant wishes to withdraw or on the advice of their general practitioner or midwife.
Death.
Clinician led (any change in the participant’s condition that has been clinically reasoned to necessitate discontinuation of their participants, participant now meets the exclusion criterion).
Where possible, participants who are lost to follow-up will be contacted to collect outcome measures, even if they do not complete the intervention. The only exceptions to this are when consent is withdrawn or the participant is incapacitated and therefore unable to reconfirm their consent.
Ethics and dissemination
All participants will provide written informed consent and will be free to withdraw from this study at any time without giving a reason.
Results of this study will be written up as part of a doctoral thesis and disseminated through publication in peer-reviewed journals, presented at professional conferences, shared via obesity and physiotherapy related meetings and via social media, for example, Twitter. Findings will also be shared with local clinical services, commissioning groups and patient support groups. A lay summary of results will be prepared with the PPI group and provided to study participants once the study is complete. Dissemination of study results is expected in 2022.
Regulatory approval
This study has been approved by the NHS Research Ethics Committee (REC): Haydock 20/NW/0472. Any protocol modifications will be discussed with the TMG, reported to sponsor and the NHS REC.
Study status
Recruitment began in March 2021 and the study is ongoing. It is realistic to suggest that the study might still be impacted by COVID-19, which may result in it being deemed inappropriate for participants to access the research site. However, PARIS has been developed in such a way that it minimises the potential impact from COVID-19. Site visits have been reduced, and the intervention has been designed to be delivered online. If there are further COVID-19 disruptions, it might be possible for the study design to adapt to reduce site visit frequency or duration further, for example, sending out questionnaires and accelerometer via recorded delivery to avoid participants coming to the study site. This would be discussed, as appropriate with the PPI group, trial management group, study sponsor and the REC.
Ethics statements
Patient consent for publication
References
Footnotes
Twitter @Physio_JJ
Contributors JJ led on the conception and design of this work thus making a substantial contribution; they drafted and revised the manuscript for important intellectual content, and is the principal investigator on the study to which the protocol relates. MG made a substantial contribution to the design of the work, and revised the manuscript for important intellectual content. HE made substantial contributions to the conception and design of the work, including the analysis of data that was integral to the development of the intervention that we have outlined here, and revised the work for important intellectual content. WH made substantial contributions to the conception and design of the work, including the interpretation of data that was integral to the development of the intervention that we have outlined here; drafting and revising the work for important intellectual content. JW made substantial contributions to the conception and design of this work, revising it to ensure intellectual content, and is the chief investigator on this study to which the protocol relates. All authors have agreed to the final version for submission and agree to be accountable for all aspects of the work; they will ensure that questions related to the accuracy and integrity of any part of the work are appropriately investigated and resolved.
Funding This report is independent research supported by the National Institute for Health Research (HEE/NIHR ICA Programme Clinical Doctoral Research Fellowship, Mrs Jennifer James, ICA-CDRF-2017-03-008). This research does not represent the views of the NIHR/HEE or Department for Health and Social Care.
Competing interests None declared.
Patient and public involvement Patients and/or the public were involved in the design, or conduct, or reporting, or dissemination plans of this research. Refer to the Methods section for further details.
Provenance and peer review Not commissioned; externally peer reviewed.